Cargando…
Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
The K-RAS oncogene is widely mutated in human cancers. Activating mutations in K-RAS give rise to constitutive signalling through the MAPK/ERK and PI3K/AKT pathways promoting increased cell division, reduced apoptosis and transformation. The majority of activating mutations in K-RAS are located in c...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056876/ https://www.ncbi.nlm.nih.gov/pubmed/21371307 http://dx.doi.org/10.1186/1750-2187-6-2 |